(Q36708527)

15 August 2017

1 reference

title

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases (English)

1 reference

15 August 2017

Canan Yücesan

1

1 reference

15 August 2017

Onder Arslan

2

1 reference

15 August 2017

Mutlu Arat

3

1 reference

15 August 2017

Nezih Yücemen

4

1 reference

15 August 2017

Erol Ayyildiz

5

1 reference

15 August 2017

Osman Ilhan

6

1 reference

15 August 2017

Nermin Mutluer

7

1 reference

15 August 2017

publication date

16 January 2007

1 reference

Transfusion and Apheresis Science

15 August 2017

published in

1 reference

15 August 2017

volume

36

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

103-107

1 reference

Therapeutic apheresis in neurological disorders

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Remission of myasthenia gravis following plasma-exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in myasthenia gravis. A comparative study of daily versus alternately daily schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

The value of plasmapheresis in the treatment of acute and chronic Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain-Barré syndrome associated with anti-GM1b IgG antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Progressive encephalomyelitis with rigidity responsive to plasmapheresis and immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Hashimoto's encephalopathy responding to plasmapheresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Treatment of central pontine myelinolysis with therapeutic plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Safety of plasmapheresis in the treatment of neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Double filtration plasmapheresis in myasthenia gravis--analysis of clinical efficacy and prognostic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in multiple sclerosis: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in acute attacks of multiple sclerosis: The cons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Therapeutic trial of plasma exchange in osteosclerotic myeloma associated with the POEMS syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in fulminant acute disseminated encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Acute disseminated encephalomyelitis in a pregnant woman successfully treated with plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Plasmapheresis in a child affected by acute disseminated encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: successful treatment with plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Neuropsychiatric Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Isaacs' syndrome successfully treated by immunoadsorption plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.06.008

10.1016/J.TRANSCI.2006.06.008

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference